Luke is visiting from Amsterdam UMC, and is working on developing polygenic risk scores for atherosclerosis and cardiometabolic traits using AtheroExpress and UK Biobank genetic data. His other projects include in situ transcriptomic mapping of macrophages and T cells in human plaques, and implementation of machine-learning based 'multiPRS' methods to better characterise cardiovascular disease etiologies. All projects are part of the MIRACLE Marie Curie doctoral network.